NeuroOne Medical Technologies Profit Margin

NeuroOne Medical Technologies (NMTC) currently reports a profit margin of -71.51% as of June 2026. That compares with -80.51% in the prior-year period — up 11.2% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore NeuroOne Medical Technologies's profit margin history and peer comparisons.

NeuroOne Medical Technologies's profit margin increased from -80.51% to -71.51% — a 11.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroOne Medical Technologies's profit margin of -71.51% is lower than the its sector sector average of 13.23%. That is roughly 640.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but NeuroOne Medical Technologies's current -71.51% should be judged against industry norms (sector average: 13.23%) and against NMTC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -71.51%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for NeuroOne Medical Technologies, and consider following NMTC for alerts when major investors trade the stock.